Mentice publishes the company’s interim report for the period January–September 2019
Continued expansion, but the medical device industry is lagging Third quarter 2019 · Net sales amounted to 29.3 (35.6) MSEK. · Operating result for the period before depreciations (EBITDA) totaled -6.7 (1.3) MSEK. · Net result for the period amounted to -9.0 (-0.3) MSEK. · Earnings per share (EPS) was -0.37 (-0.03) SEK. · Order intake amounted to 24.4 (49.2) MSEK. · The order book was 47.0 (55.0) MSEK. · Cash flow from operating activities totaled -16.2 (2.9) MSEK. January-September 2019 · Net sales amounted to 89.1 (91.9) MSEK. · Operating result for